Get started
Author

Zakariya Kashour

Observed name: Z Kashour
ORCID: 0000-0002-1527-9783
Observed ORCID: 0000-0002-1527-9783
OpenAlex ID: A5087865615
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
2020 · Imad M. Tleyjeh, Zakariya Kashour, et al. · Clinical Microbiology and Infection · 205
PDF
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
2020 · Zakariya Kashour, Muhammad Riaz, et al. · Journal of Antimicrobial Chemotherapy · 133
PDF
Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis
2020 · Imad M. Tleyjeh, Zakariya Kashour, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 64
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
2021 · Imad M. Tleyjeh, Zakariya Kashour, et al. · Clinical Microbiology and Infection · 53
PDF
Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades
2019 · Nariman Sepehrvand, Wendimagegn Alemayehu, et al. · JAMA Cardiology · 41
PDF
Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
2023 · Hassan Awada, Mina Abdelmalek, et al. · Blood Cancer Journal · 11
PDF
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
2021 · Zakariya Kashour, Tarek Kashour, et al. · Clinical and Translational Science · 10
PDF
POSTER: CT-646 The Future Landscape of Graft vs Host Disease Prevention Trials
2023 · Vasanthan Muthusamy Kumarasamy, Zakariya Kashour, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-646 The Future Landscape of Graft vs Host Disease Prevention Trials
2023 · Vasanthan Muthusamy Kumarasamy, Zakariya Kashour, et al. · Clinical Lymphoma Myeloma & Leukemia
Gemtuzumab Ozogamicin Plus Standard Induction Chemotherapy Improves Outcomes in Intermediate Risk Cytogenetic Acute Myeloid Leukemia
2022 · Hassan Awada, Mina Abdelmalek, et al. · Blood
2131Pragmatic clinical trials in cardiovascular medicine: trends over time in major medical journals
2019 · N Sepehrvand, W Alemayehu, et al. · European Heart Journal
Works count: 11
Citation count: 517
H-index: 7
I10-index: 7
Year
Topic
Type